Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris

Clinica Chimica Acta

Volumn 391, Issue 1-2, 2008, Pages 18-23

  Consuegra Sanchez, Luciano ^a   Petrovic, Ivana ^a   Cosin Sales, Juan ^a   Holt, David W ^a   Christiansen, Michael ^b   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Chronic stable angina; Long term mortality; PAPP A; pro MBP

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MAJOR BASIC PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; REVASCULARIZATION; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; EOSINOPHIL MAJOR BASIC PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROGNOSIS;

ANGINA;

EID: 41949132944     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.01.012     Document Type: Article

References (17)

1. Lund J., Qin Q.P., Ilva T., et al. Circulating pregnancy-associated plasma protein predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 108 (2003) 1924-1926
2. Heeschen C., Dimmeler S., Hamm C.W., et al. Investigators CS. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 45 (2005) 229-237
3. Bayes-Genis A., Conover C.A., Overgaard M.T., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345 (2001) 1022-1029
4. Cosin-Sales J., Kaski J.C., Christiansen M., et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 26 (2005) 2093-2098
5. Cosin-Sales J., Christiansen M., Kaminski P., et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 109 (2004) 1724-1728
6. Elesber A.A., Conover C.A., Denktas A.E., et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J 27 (2006) 1678-1684
7. Overgaard M.T., Haaning J., Boldt H.B., et al. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275 (2000) 31128-31133
8. Sullivan D.R., Marwick T.H., and Freedman S.B. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 119 (1990) 1262-1279
9. Christiansen M., Jaliashvili I., Overgaard M.T., et al. Quantification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid. Clin Chem 46 (2000) 1099-1105
10. Laursen L.S., Overgaard M.T., Soe R., et al. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 504 (2001) 36-40
11. Bayes-Genis A., Conover C.A., and Schwartz R.S. The insulin -like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 86 (2000) 125-130
12. Conti E., Carrozza C., Capoluongo E., et al. Insulin-like growth factor-1 as a vascular protective factor. Circulation 110 (2004) 2260-2265
13. Crea F., and Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend or foe?. Eur Heart J 26 (2005) 2075-2076
14. Kaski J.C., Chester M.R., Chen L., et al. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 92 (1995) 2058-2065
15. Knuiman M.W., Divitini M.L., Buzas J.S., et al. Adjustment for regression dilution in epidemiological regression analyses. Ann Epidemiol 8 (1998) 56-63
16. Qin Q.P., Kokkala S., Lund J., et al. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem 52 (2006) 1619-1620
17. Wittfooth S., Qin Q.P., Lund J., et al. Immunofluorometric point-of-care assays for the detection of ACS related non-complexed PAPP-A. Clin Chem 52 (2006) 1794-1801